Market Share of Global Methicillin-resistant Staphylococcus Aureus Drugs Industry
Key players operating in the Methicillin-resistant Staphylococcus Aureus Drugs Market include Cumberland Pharmaceuticals Inc., Pfizer Inc., AbbVie Inc., Melinta Therapeutics Inc., Merck & Co Inc., Theravance Biopharma, Basilea Pharmaceutica, AmpliPhi Biosciences Corporation, Teva Pharmaceutical Industries Ltd, Nabriva Therapeutics Plc., Paratek Pharmaceuticals, Inc., Innovation Pharmaceuticals Inc., and Debiopharm International S.A.
Methicillin Resistant Staphylococcus Aureus Drugs Market Leaders
Pfizer Inc
Cumberland Pharmaceuticals Inc
Melinta Therapeutics Inc
Merck & Co Inc
AbbVie Inc.
*Disclaimer: Major Players sorted in no particular order